Gopal Iyer Profile
Gopal Iyer

@DrGopalIyer

Followers
442
Following
2K
Media
65
Statuses
1K

Professor, Head and Neck Surgeon, Clinician-scientist, budding immunologist, trainee architect. Views expressed are my own & not reflective of my affiliations.

Singapore
Joined May 2021
Don't wanna be here? Send us removal request.
@DrGopalIyer
Gopal Iyer
2 months
RT @EngEongOoi: AS01-adjuvanted vaccine alters baseline correlates of T cell response .
0
1
0
@grok
Grok
10 days
The most fun image & video creation tool in the world is here. Try it for free in the Grok App.
0
123
979
@DrGopalIyer
Gopal Iyer
4 months
RT @oncologytube: 🔑KEYNOTE-689 Update at #AACR25 new standard?.🌟Neoadjuvant + adjuvant #pembrolizumab in LA-HNSCC.🌟 EFS HR: 0.73 (95% CI 0.….
0
9
0
@DrGopalIyer
Gopal Iyer
6 months
Finally got my hands on the real thing!!! @VinPaleri @DrNarayanaSub @drbruceashford @duvvuri_md
Tweet media one
1
0
9
@DrGopalIyer
Gopal Iyer
6 months
Nothing like hanging with friends from half way across the world, enjoying simple pleasures. Walter Lee from duke… @kaisinyee @duvvuri_md @drbruceashford
Tweet media one
4
0
9
@DrGopalIyer
Gopal Iyer
7 months
Aspirin after completion of standard adjuvant therapy for colorectal cancer (ASCOLT): an international, multicentre, phase 3, randomised, double-blind, placebo-controlled trial - The Lancet Gastroenterology & Hepatology Amazing work led by my colleagues!!.
Tweet card summary image
thelancet.com
In patients with colorectal cancer, aspirin 200 mg daily for 3 years after completion of standard adjuvant therapy was well tolerated but did not significantly improve disease-free survival.
1
4
15
@DrGopalIyer
Gopal Iyer
7 months
RT @DrMLChua: Our 2nd work supporting chromatin-related adaptation for acquired #Radioresistance in #HeadNeckCancer ! . Collab with @echow3….
0
2
0
@DrGopalIyer
Gopal Iyer
8 months
Great review on gamma-delta T cells for cell therapy by my hardworking PhD student Weikiang Lim !! Thanks to @esmo_iotech and @HaanenJohn .
0
0
3
@DrGopalIyer
Gopal Iyer
9 months
Greatest joy in getting together friends from all over the world @DrMLChua @lucmorrisnyc @echow310
Tweet media one
2
0
8
@DrGopalIyer
Gopal Iyer
11 months
Last of a fantastic meeting!! So many great talks but a lot left to do in Indonesia !! #iicc
Tweet media one
0
0
7
@DrGopalIyer
Gopal Iyer
11 months
Amazing meeting in Bali! A tour de force of intent by the Indonesia to drive cancer prevention and treatment for the next decade!!! #iicc @RebeccaDSing
Tweet media one
0
0
11
@DrGopalIyer
Gopal Iyer
11 months
Shockingly accurate and universal!!!!! @drbruceashford.
@bonchieredstate
Bonchie
11 months
This goes so hard.
0
0
1
@DrGopalIyer
Gopal Iyer
1 year
Fundraising for cancer research and care!!! @danieltanmd @DrMLChua @elizafongls @ChiaClaramae @Valeriechew29
Tweet media one
Tweet media two
2
0
8
@DrGopalIyer
Gopal Iyer
1 year
Single protein makes the difference for this potential EV-based therapeutic #notvoodoo @ElizSMcKenna 🤣🤣🤣.
@DrGopalIyer
Gopal Iyer
1 year
It’s finally out…exosomes as a potential cancer therapeutic due to the presence of a single protein EGFR Isoform D… took us to realm of splicing, exosomes, endosomal signaling and more recently manufacturing….who knew!!!.A brief summary:.
0
2
4
@DrGopalIyer
Gopal Iyer
1 year
Potential (we hope) a whole new therapeutic pathway to convert EGFRG dependent cancer to EGFR druggable cancers!.
1
0
0
@DrGopalIyer
Gopal Iyer
1 year
This could be transferred even by IP injections in animals and signaled through endosomal trafficking and likely activates src phosphorylation.
1
0
0
@DrGopalIyer
Gopal Iyer
1 year
then we dissected the mechanism and found that the secretion of extracellular vesicles with the splice variant responsible for the sensitivity phenotype was sufficient to confer sensitivity in vitro and in vivo.
1
0
0